The 20 Best Ataxia-Telangiectasia Doctors Near Me in Michigan, US

Sharan Srinivasan is a Neurologist in Ann Arbor, Michigan. Dr. Srinivasan has been practicing medicine for over 10 years and is rated as a Distinguished provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Hereditary Ataxia, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 4, and Spinocerebellar Ataxia Type 5.

Vikram Shakkottai is a Neurologist in Ann Arbor, Michigan. Dr. Shakkottai is rated as a Distinguished provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.

Michael Deweerd is a primary care provider, practicing in Family Medicine in Fremont, Michigan. Dr. Deweerd has been practicing medicine for over 28 years and is rated as an Advanced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Ataxia-Telangiectasia, Type 2 Diabetes (T2D), Diabetic Nephropathy, and Chronic Cough.

Peter K. Todd, M.D., Ph.D., is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Todd earned his Bachelor of Science degree in 1994 from the University of California, San Diego. He then entered the Medical Science Training Program at the University of Wisconsin at Madison, where he completed his doctorate in 2002 and medical degree in 2004. His Ph.D research focused on synaptic defects in Fragile X Syndrome, a common inherited cause of cognitive impairment in children.He completed his internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. While there, he did research on the role of the ubiquitin proteasome system and autophagy in Spinal and Bulbar Muscular Atrophy, a polyglutamine disorder, and Fragile X Tremor Ataxia Syndrome (FXTAS). He came to the U-M in 2008 for a clinical and research fellowship in movement disorders and neurogenetics.Todd joined the U-M faculty in 2010 as an assistant professor in movement disorders and neurogenetics, working in the laboratory of Henry L. Paulson, M.D., Ph.D., in the Center for Neurodegenerative Research.His current research is focused on the mechanisms underlying RNA-mediated neurodegeneration in FXTAS and myotonic dystrophy, and how these mechanisms may overlap and inform our understanding of other neurodegenerative disorders. He also sees patients with movement disorders and inherited neurological disease.Dr. Todd has received several academic awards, including a Howard Hughes Undergraduate Research Fellowship, the Francis M. Forester Prize for promise as an academic neurologist, the Samuel Ziritzky Prize for most outstanding research by a neurology resident at Penn and prizes for excellence in research at the International Conference on Unstable Microsatellites in Human Disease, and the U-M neuroscience day. Most recently, Dr Todd received the S. Weir Mitchell Alliance award from the American Academy of Neurology which each year recognizes one early investigator physician scientist who has made important contributions to basic science in neurological disorders.A member of the American Medical Association and the American Academy of Neurology, he has served as an ad-hoc reviewer for the Journal of Biological Chemistry, Neurology, Proceedings of the National Academy of Sciences, Neuron, Science and Human Molecular Genetics.His bibliography includes several peer-reviewed papers, editorials, book reviews and chapters, abstracts and online. Dr. Todd is rated as an Advanced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Fragile X Syndrome, Fragile XE Syndrome, Hereditary Ataxia, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

Dr. Thomas Michniacki was raised in Memphis, Michigan and attended the University of Michigan for his undergraduate studies. Following graduation from the University of Michigan Medical School, he completed his pediatric residency training at the University of Colorado/Children’s Hospital Colorado. Dr. Michniacki returned to his home state of Michigan for his fellowship training in pediatric hematology/oncology at the University of Michigan and is now a faculty member within the department. His clinical and research interests include immune-mediated hematologic disorders, bone marrow failure syndromes/aplastic anemia and primary immunodeficiencies. He enjoys attending University of Michigan sporting events and exploring the city of Ann Arbor with his wife. Dr. Michniacki is rated as an Advanced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Aplastic Anemia, Febrile Neutropenia, Hereditary Spherocytosis, Hemophagocytic Lymphohistiocytosis, and Bone Marrow Transplant.

Jordan Taylor is a Neurologist in Wyoming, Michigan. Dr. Taylor is rated as an Advanced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Migraine, Seizures, Ataxia-Telangiectasia, Transmyocardial Revascularization, and Stent Placement.

Rajen Mody is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Mody is rated as an Advanced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Infantile Neutropenia, Glioma, and Bone Marrow Aspiration.

Erin Knierbein is a Neuromusculoskeletal Medicine specialist and a Pediatric Neurologist in Ann Arbor, Michigan. Dr. Knierbein is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. Her top areas of expertise are Danon Disease, Pompe Disease, Dysferlinopathy, and Duchenne Muscular Dystrophy.

My past and ongoing research is focused on translational studies and clinical trials for children with brain and spinal cord tumors with a special emphasis on ependymoma and ATRT. Children with brain tumors continue to have poor outcomes compared to those with other cancers in this age group. I have analyzed the outcomes of treatment for ATRT and ependymoma in children, combining traditional modes of therapy, such as surgery, chemotherapy, and radiation therapy, with molecularly targeted therapy. In the process we have identified novel clinical and molecular risk factors associated with outcomes. By identifying clinical risk factors associated with poor outcomes in these children, we can tailor therapy to improve outcomes in those at highest risk of treatment failures. Dr. Upadhyaya is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Rhabdoid Tumor, Teratoma of the Mediastinum, Glioma, Medulloblastoma, and Bone Marrow Aspiration.

Kelly Walkovich is a Pediatrics provider in Ann Arbor, Michigan. Dr. Walkovich is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Infantile Neutropenia, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Valerie Opipari is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Opipari is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. Her top areas of expertise are Neuroblastoma, Hereditary Neuroblastoma, Acute Lymphoblastic Leukemia (ALL), Osteosarcoma, and Bone Marrow Aspiration.

Gobind Garg is a primary care provider, practicing in Internal Medicine in Oak Park, Michigan. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Transient Ischemic Attack (TIA), Retinopathy Arteriosclerotic, Deep Vein Thrombosis, Childhood Iron Deficiency Anemia, and Endoscopy.

Jack Cribb is a primary care provider, practicing in Internal Medicine in Charlotte, Michigan. Dr. Cribb is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Pulmonary Embolism, Chronic Cough, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension.

Gandhi Lanke is a primary care provider, practicing in Internal Medicine in Flint, Michigan. Dr. Lanke is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Jaundice, Sepsis, Cholecystitis, Endoscopy, and Pancreaticoduodenectomy.

Dr. Sahai is the Leader of the Gastrointestinal Medical Oncology Section and Associate Professor in the Division of Hematology-Oncology, Department of Internal Medicine. Dr. Sahai is also a member of the University of Michigan Rogel Cancer Center and Director of Tumor Response Assessment Core.Dr. Sahai attended medical school at the Government Medical College at Amritsar with the Baba Farid University of Health Science in India. He then completed his Masters in Clinical Epidemiology at Harvard School of Public Health followed by Internal Medicine residency training at University of Pittsburgh where he met his wife. He completed his fellowship in Hematology-Oncology at Northwestern University where he also served as the Chief Fellow. Subsequently, Dr. Sahai joined University of Michigan as Assistant Professor in Internal Medicine in 2013.Dr. Sahai is a clinician-scientist who sees patients within the Multidisciplinary Pancreatic and Liver Tumor programs. As a clinical investigator he is the Principal Investigator on several investigator-initiated clinical trials open across the U.S. His translational research program leverages the pancreaticobiliary cancer biobanks that he directs for the therapeutic investigation of novel compounds in patient-derived cell lines and xenograft models to help develop novel phase 1/2 investigator-initiated clinical trials. Dr. Sahai is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Familial Pancreatic Cancer, and Neuroendocrine Tumor.

Raymond Hutchinson is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Hutchinson is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Fanconi Anemia, Shwachman-Diamond Syndrome, Ataxia-Pancytopenia Syndrome, and Wiskott-Aldrich Syndrome.

Lawrence Lum is a Pediatrics provider in Detroit, Michigan. Dr. Lum is rated as an Experienced provider by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Breast Cancer, Graft Versus Host Disease (GvHD), Multiple Myeloma, Angioimmunoblastic T-cell Lymphoma, and Bone Marrow Transplant.